Noncontrast MRI with diffusion-weighted imaging as the sole imaging modality for detecting liver malignancy in patients with high risk for hepatocellular carcinoma
- 1 July 2014
- journal article
- Published by Elsevier in Magnetic Resonance Imaging
- Vol. 32 (6) , 610-618
Abstract
No abstract availableKeywords
This publication has 32 references indexed in Scilit:
- The Role of Imaging in Hepatocellular CarcinomaJournal of Clinical Gastroenterology, 2013
- Infiltrating Hepatocellular Carcinoma: Seeing the Tree through the ForestJournal of Gastrointestinal Surgery, 2011
- New MR imaging criteria with a diffusion-weighted sequence for the diagnosis of hepatocellular carcinoma in chronic liver diseasesJournal of Hepatology, 2011
- Management of Hepatocellular Carcinoma: An Update ΔσHepatology, 2011
- APASL and AASLD Consensus Guidelines on Imaging Diagnosis of Hepatocellular Carcinoma: A ReviewInternational Journal of Hepatology, 2011
- Diffusion-weighted MR Imaging of the LiverRadiology, 2010
- Exposure to Low-Dose Ionizing Radiation from Medical Imaging ProceduresNew England Journal of Medicine, 2009
- Nephrogenic Systemic Fibrosis: Risk Factors and Incidence EstimationRadiology, 2007
- Hepatic Metastases: Diffusion-weighted Sensitivity-encoding versus SPIO-enhanced MR ImagingRadiology, 2006
- Contrast-Induced NephropathyAmerican Journal of Roentgenology, 2004